203 related articles for article (PubMed ID: 10203710)
21. T-cell immunometabolism against cancer.
Jiang S; Yan W
Cancer Lett; 2016 Nov; 382(2):255-258. PubMed ID: 27664755
[TBL] [Abstract][Full Text] [Related]
22. Making and circumventing tolerance to cancer.
Kammertoens T; Blankenstein T
Eur J Immunol; 2009 Sep; 39(9):2345-53. PubMed ID: 19634191
[TBL] [Abstract][Full Text] [Related]
23. The emerging Protumor role of γδ T lymphocytes: implications for cancer immunotherapy.
Rei M; Pennington DJ; Silva-Santos B
Cancer Res; 2015 Mar; 75(5):798-802. PubMed ID: 25660949
[TBL] [Abstract][Full Text] [Related]
24. Expression of TCR zeta chain of tumor associated lymphocytes from malignant pleural effusions.
Sikora J; Dworacki G; Zeromski J
Adv Exp Med Biol; 2001; 495():325-9. PubMed ID: 11774587
[No Abstract] [Full Text] [Related]
25. Cancer Immunotherapy: Theory and Application.
Chen G; Bodogai M; Tamehiro N; Shen C; Dou J
J Immunol Res; 2018; 2018():7502161. PubMed ID: 30035133
[No Abstract] [Full Text] [Related]
26. Possible Application of Ascites-infiltrating Gamma-delta T Cells for Adoptive Immunotherapy.
Abe Y; Kobayashi H; Akizawa Y; Ishitani K; Hashimoto K; Matsui H
Anticancer Res; 2018 Jul; 38(7):4327-4331. PubMed ID: 29970569
[TBL] [Abstract][Full Text] [Related]
27. Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic γδ T lymphocytes to tumor beds.
Lança T; Costa MF; Gonçalves-Sousa N; Rei M; Grosso AR; Penido C; Silva-Santos B
J Immunol; 2013 Jun; 190(12):6673-80. PubMed ID: 23686489
[TBL] [Abstract][Full Text] [Related]
28. Anti-tumor effects of human peripheral gammadelta T cells in a mouse tumor model.
Zheng BJ; Chan KW; Im S; Chua D; Sham JS; Tin PC; He ZM; Ng MH
Int J Cancer; 2001 May; 92(3):421-5. PubMed ID: 11291081
[TBL] [Abstract][Full Text] [Related]
29. New checkpoints in cancer immunotherapy.
Ni L; Dong C
Immunol Rev; 2017 Mar; 276(1):52-65. PubMed ID: 28258699
[TBL] [Abstract][Full Text] [Related]
30. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications.
Zhang Y; Zhang Z
Cell Mol Immunol; 2020 Aug; 17(8):807-821. PubMed ID: 32612154
[TBL] [Abstract][Full Text] [Related]
31. Booming cancer immunotherapy fighting tumors.
Li D; Wang W
Sci China Life Sci; 2017 Dec; 60(12):1445-1449. PubMed ID: 29170888
[No Abstract] [Full Text] [Related]
32. Prevailing over T cell exhaustion: New developments in the immunotherapy of pancreatic cancer.
Bauer C; Kühnemuth B; Duewell P; Ormanns S; Gress T; Schnurr M
Cancer Lett; 2016 Oct; 381(1):259-68. PubMed ID: 26968250
[TBL] [Abstract][Full Text] [Related]
33. Adoptive T cell therapy for cancer in the clinic.
June CH
J Clin Invest; 2007 Jun; 117(6):1466-76. PubMed ID: 17549249
[TBL] [Abstract][Full Text] [Related]
34. Activation of T lymphocytes for the adoptive immunotherapy of cancer.
Sussman JJ; Shu S; Sondak VK; Chang AE
Ann Surg Oncol; 1994 Jul; 1(4):296-306. PubMed ID: 7850528
[TBL] [Abstract][Full Text] [Related]
35. A power surge for cancer immunotherapy: antibodies, vaccines, and engineered T cells fuel new optimism.
Nelson B
Cancer Cytopathol; 2014 Jan; 122(1):1-2. PubMed ID: 24424750
[No Abstract] [Full Text] [Related]
36. Manipulation of costimulatory signals to enhance antitumor T-cell responses.
Allison JP; Hurwitz AA; Leach DR
Curr Opin Immunol; 1995 Oct; 7(5):682-6. PubMed ID: 8573312
[TBL] [Abstract][Full Text] [Related]
37. CAR T Cell Therapy for Solid Tumors.
Newick K; O'Brien S; Moon E; Albelda SM
Annu Rev Med; 2017 Jan; 68():139-152. PubMed ID: 27860544
[TBL] [Abstract][Full Text] [Related]
38. Targeting tumours with genetically enhanced T lymphocytes.
Sadelain M; Rivière I; Brentjens R
Nat Rev Cancer; 2003 Jan; 3(1):35-45. PubMed ID: 12509765
[TBL] [Abstract][Full Text] [Related]
39. [Immunity and immunosuppression in tumor growth].
Govallo VI
Vopr Onkol; 1987; 33(4):91-9. PubMed ID: 3296437
[No Abstract] [Full Text] [Related]
40. Preventing abnormalities in signal transduction of T cells in cancer: the promise of cytokine gene therapy.
Zier K; Gansbacher B; Salvadori S
Immunol Today; 1996 Jan; 17(1):39-45. PubMed ID: 8652051
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
